Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000053

Chief Scientific Officer sold 3,242 shares at an average $15.12 ($49,004)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sethuraman Natarajan Chief Scientific Officer 2024-09-06 Sale 10b5-1 −600 $15.24 $9,141 186,458 D
Sethuraman Natarajan Chief Scientific Officer 2024-09-09 Sale 10b5-1 −2,642 $15.09 $39,862 183,816 D
Open-market sales · 3,242 sh · avg $15.12 · $49,004
Loading xslF345X05/wk-form4_1726000325.xml…